Matthew Strobeck Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew Strobeck.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew Strobeck. Matthew Strobeck is a Director in Accelerate Diagnostics, Inc ($AXK) and a Director in QUIDEL CORP /DE/ ($QDEL) and a Director in METABOLIX, INC. ($MBLX) and a in BIODESIX INC ($BDSX) and a Director in BIODESIX INC ($BDSX).
Address: C/O METABOLIX, INC. 21 ERIE STREET CAMBRIDGE 02139 MA
Companies in which Matthew Strobeck is an Insider
Accelerate Diagnostics, Inc
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Matthew Strobeck: Director
Holdings: 187,297 shares
Latest Transaction: May 24 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIODESIX INC
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Matthew Strobeck:
Holdings: 943,535 shares
Latest Transaction: Dec 09 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
QUIDEL CORP /DE/
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Matthew Strobeck: Director
Holdings: 4,909 shares
Current Value: $97,542
Latest Transaction: May 14 2021
$QDEL Market Capitalization: $640.78M
$QDEL Previous Close: $19.87
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
YIELD10 BIOSCIENCE, INC.
Industry: MISCELLANEOUS PLASTIC PRODUCTS [3080]
Position of Matthew Strobeck: Director
Holdings: 0 shares
Latest Transaction: Jan 28 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Matthew Strobeck
Sentiment: All, AXK, BDSX, QDEL, MBLX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2021 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Option Exercise | A | 7.68 | 35,168 | 270,090 | 35,168 | |
| May 14 2021 | QDEL | QUIDEL CORP /DE/ | Strobeck Matthew | Director | Option Exercise | M | 0.00 | 1,040 | 0 | 0 | |
| May 14 2021 | QDEL | QUIDEL CORP /DE/ | Strobeck Matthew | Director | Buy | M | 0.00 | 1,040 | 0 | 4,909 | 3.9 K to 4.9 K (+26.88 %) |
| Apr 13 2021 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Grant | A | 7.68 | 19,531 | 149,998 | 187,297 | 167.8 K to 187.3 K (+11.64 %) |
| Feb 24 2021 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Grant | A | 7.68 | 19,531 | 149,998 | 167,766 | 148.2 K to 167.8 K (+13.18 %) |
| Dec 09 2020 | BDSX | BIODESIX INC | Strobeck Matthew | Option Exercise | M | 6.83 | 23,440 | 160,095 | 11,718 | ||
| Dec 09 2020 | BDSX | BIODESIX INC | Strobeck Matthew | Option Exercise | M | 6.83 | 35,157 | 240,122 | 1 |